Group B streptococcal (GBS) infection remains the most common cause of neonatal early-
onset sepsis and a signiicant cause of late-onset sepsis among young infants …

During the 1990s the focus of group B streptococcus (GBS) disease research has shifted to
prevention. Increased use of intrapartum antimicrobial prophylaxis in North America and …

Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease
since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the …

Group B streptococcus (GBS) remains a leading cause of serious neonatal infection despite
great progress in perinatal GBS disease prevention in the 1990s. In 1996, CDC, in …

Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal
disease. Since the end of the 1990s, various strategies for prevention of the early onset …

Background. Early-onset group B streptococcal (GBS) prevention efforts are based on
targeted use of intrapartum antibiotic prophylaxis (IAP); applicability of these prevention …

Volume 42 Number 5 May 2016 233 developed by our research team for use in an
integrated health care delivery system. In this article, we describe the strategy and the tools …

Background. Few data are available on the outcome of neonatal sepsis evaluations in an
era when intrapartum antibiotic therapy is common. Methods. We identified all newborns …

abstract Objectives: To quantify risk factors for and the prevalence of early onset group B
streptococcal sepsis in neonates in a geographically defined population. Design: Cases …

The burden of early onset neonatal sepsis due to group B Streptococcus (GBS) has declined
substantially over the past 20 years as a result of widespread use of intrapartum antibiotic …